FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2082879053> ?p ?o ?g. }

• W2082879053 endingPage "1544" @default.
• W2082879053 startingPage "1535" @default.
• W2082879053 abstract "In certain cancers, expression of CXCL16 and its receptor CXCR6 associate with lymphocyte infiltration, possibly aiding anti-tumour immune response. In other cancers, CXCL16 and CXCR6 associate with pro-metastatic activity. In the current study, we aimed to characterise the role of CXCL16, sCXCL16, and CXCR6 in ovarian cancer (OC).CXCL16/CXCR6 expression was analysed on tissue microarray containing 306 OC patient samples. Pre-treatment serum sCXCL16 was determined in 118 patients using ELISA. In vitro, (primary) OC cells were treated with an ADAM-10/ADAM-17 inhibitor (TAPI-2) and an ADAM-10-specific inhibitor (GI254023x), whereupon CXCL16 levels were evaluated on the cell membrane (immunofluorescent analysis, western blots) and in culture supernatants (ELISA). In addition, cell migration was assessed using scratch assays.sCXCL16 independently predicted for poor survival (hazard ratio=2.28, 95% confidence interval=1.29-4.02, P=0.005), whereas neither CXCL16 nor CXCR6 expression correlated with survival. Further, CXCL16/CXCR6 expression and serum sCXCL16 levels did not associate with lymphocyte infiltration. In vitro inhibition of both ADAM-17 and ADAM-10, but especially the latter, decreased CXCL16 membrane shedding and strongly reduced cell migration of A2780 and cultured primary OC-derived malignant cells.High serum sCXCL16 is a prognostic marker for poor survival of OC patients, possibly reflecting ADAM-10 and ADAM-17 pro-metastatic activity. Therefore, serum sCXCL16 levels may be a pseudomarker that identifies patients with highly metastatic tumours." @default.
• W2082879053 created "2016-06-24" @default.
• W2082879053 creator A5001268928 @default.
• W2082879053 creator A5003131962 @default.
• W2082879053 creator A5011238250 @default.
• W2082879053 creator A5017438678 @default.
• W2082879053 creator A5018392015 @default.
• W2082879053 creator A5023772387 @default.
• W2082879053 creator A5041782447 @default.
• W2082879053 creator A5064920206 @default.
• W2082879053 creator A5068364166 @default.
• W2082879053 creator A5089778955 @default.
• W2082879053 creator A5089879675 @default.
• W2082879053 date "2014-02-11" @default.
• W2082879053 modified "2023-10-08" @default.
• W2082879053 title "Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity" @default.
• W2082879053 cites W1943615635 @default.
• W2082879053 cites W1969287946 @default.
• W2082879053 cites W1970458434 @default.
• W2082879053 cites W1983372237 @default.
• W2082879053 cites W1988335934 @default.
• W2082879053 cites W1994859763 @default.
• W2082879053 cites W2000090486 @default.
• W2082879053 cites W2030637628 @default.
• W2082879053 cites W2042020498 @default.
• W2082879053 cites W2044330918 @default.
• W2082879053 cites W2045622596 @default.
• W2082879053 cites W2046375739 @default.
• W2082879053 cites W2066871159 @default.
• W2082879053 cites W2066912909 @default.
• W2082879053 cites W2073767069 @default.
• W2082879053 cites W2083670478 @default.
• W2082879053 cites W2087810003 @default.
• W2082879053 cites W2093728029 @default.
• W2082879053 cites W2093987168 @default.
• W2082879053 cites W2098992368 @default.
• W2082879053 cites W2101995865 @default.
• W2082879053 cites W2105173724 @default.
• W2082879053 cites W2108592152 @default.
• W2082879053 cites W2116058997 @default.
• W2082879053 cites W2122419529 @default.
• W2082879053 cites W2143058552 @default.
• W2082879053 cites W2143240427 @default.
• W2082879053 cites W2157668882 @default.
• W2082879053 cites W2161215474 @default.
• W2082879053 cites W2166083817 @default.
• W2082879053 cites W2166159531 @default.
• W2082879053 cites W4211147776 @default.
• W2082879053 cites W4255602882 @default.
• W2082879053 cites W97158386 @default.
• W2082879053 doi "https://doi.org/10.1038/bjc.2014.55" @default.
• W2082879053 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3960624" @default.
• W2082879053 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24518602" @default.
• W2082879053 hasPublicationYear "2014" @default.
• W2082879053 type Work @default.
• W2082879053 sameAs 2082879053 @default.
• W2082879053 citedByCount "32" @default.
• W2082879053 countsByYear W20828790532014 @default.
• W2082879053 countsByYear W20828790532015 @default.
• W2082879053 countsByYear W20828790532016 @default.
• W2082879053 countsByYear W20828790532017 @default.
• W2082879053 countsByYear W20828790532018 @default.
• W2082879053 countsByYear W20828790532019 @default.
• W2082879053 countsByYear W20828790532020 @default.
• W2082879053 countsByYear W20828790532021 @default.
• W2082879053 countsByYear W20828790532022 @default.
• W2082879053 countsByYear W20828790532023 @default.
• W2082879053 crossrefType "journal-article" @default.
• W2082879053 hasAuthorship W2082879053A5001268928 @default.
• W2082879053 hasAuthorship W2082879053A5003131962 @default.
• W2082879053 hasAuthorship W2082879053A5011238250 @default.
• W2082879053 hasAuthorship W2082879053A5017438678 @default.
• W2082879053 hasAuthorship W2082879053A5018392015 @default.
• W2082879053 hasAuthorship W2082879053A5023772387 @default.
• W2082879053 hasAuthorship W2082879053A5041782447 @default.
• W2082879053 hasAuthorship W2082879053A5064920206 @default.
• W2082879053 hasAuthorship W2082879053A5068364166 @default.
• W2082879053 hasAuthorship W2082879053A5089778955 @default.
• W2082879053 hasAuthorship W2082879053A5089879675 @default.
• W2082879053 hasBestOaLocation W20828790532 @default.
• W2082879053 hasConcept C121608353 @default.
• W2082879053 hasConcept C126322002 @default.
• W2082879053 hasConcept C13373296 @default.
• W2082879053 hasConcept C134018914 @default.
• W2082879053 hasConcept C135576274 @default.
• W2082879053 hasConcept C170493617 @default.
• W2082879053 hasConcept C203014093 @default.
• W2082879053 hasConcept C2777761686 @default.
• W2082879053 hasConcept C2780427987 @default.
• W2082879053 hasConcept C502942594 @default.
• W2082879053 hasConcept C5858377 @default.
• W2082879053 hasConcept C71924100 @default.
• W2082879053 hasConcept C86803240 @default.
• W2082879053 hasConceptScore W2082879053C121608353 @default.
• W2082879053 hasConceptScore W2082879053C126322002 @default.
• W2082879053 hasConceptScore W2082879053C13373296 @default.
• W2082879053 hasConceptScore W2082879053C134018914 @default.
• W2082879053 hasConceptScore W2082879053C135576274 @default.

• next